Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

593 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J. Antoni CE, et al. Among authors: kalden jr. Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967. Arthritis Rheum. 2005. PMID: 15818699 Free article. Clinical Trial.
Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
Antoni C, Dechant C, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M, Kalden-Nemeth D, Kalden JR, Manger B. Antoni C, et al. Among authors: kalden jr, kalden nemeth d. Arthritis Rheum. 2002 Oct 15;47(5):506-12. doi: 10.1002/art.10671. Arthritis Rheum. 2002. PMID: 12382299 Free article. Clinical Trial.
Perspectives for TNF-alpha-targeting therapies.
Lorenz HM, Kalden JR. Lorenz HM, et al. Among authors: kalden jr. Arthritis Res. 2002;4 Suppl 3(Suppl 3):S17-24. doi: 10.1186/ar564. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110119 Free PMC article. Review.
593 results